Article Details

FDA Speeds Up Process for Two More Experimental Alzheimer's Drugs: Donanemab, Lecanemab

Retrieved on: 2021-06-24 15:45:00

Tags for this article:

Click the tags to see associated articles and topics

FDA Speeds Up Process for Two More Experimental Alzheimer's Drugs: Donanemab, Lecanemab. View article details on hiswai:

Excerpt

Their endings, –mab, are shorthand for monoclonal antibodies, which are laboratory-made proteins that mimic the immune system's defensive abilities ...

Article found on: www.beingpatient.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo